Antibiotic Resistance Protocols (Methods in Molecular Biology)

(C. Jardin) #1

114


a reservoir for antibiotic-resistance determi-
nants. J Med Microbiol 59:1331–1339


  1. Kristiansson C, Grape M, Gotuzzo E et al
    (2009) Socioeconomic factors and antibiotic
    use in relation to antimicrobial resistance in the
    Amazonian area of Peru. Scand J Infect Dis
    41:303–312

  2. Knudsen JD, Frimodt-møller N (2001) Animal
    models in bacteriology, vol 9. Karger, Basel,
    pp 1–14

  3. Jakobsen L, Cattoir V, Jensen KS et al (2012)
    Impact of low-level fluoroquinolone resistance
    genes qnrA1, qnrB19 and qnrS1 on ciprofloxa-
    cin treatment of isogenic Escherichia coli
    strains in a murine urinary tract infection
    model. J Antimicrob Chemother
    67:2438–2444

  4. Krych L, Hansen CHF, Hansen AK et al
    (2013) Quantitatively different, yet qualita-
    tively alike: a meta-analysis of the mouse core
    gut microbiome with a view towards the human
    gut microbiome. PLoS One 8:e62578

  5. Leatham MP, Stevenson SJ, Gauger EJ et al
    (2005) Mouse intestine selects nonmotile
    flhDC mutants of Escherichia coli MG1655
    with increased colonizing ability and better uti-
    lization of carbon sources. Infect Immun
    73:8039–8049

  6. Schjørring S, Struve C, Krogfelt KA (2008)
    Transfer of antimicrobial resistance plasmids
    from Klebsiella pneumoniae to Escherichia coli
    in the mouse intestine. J Antimicrob Chemother
    62:1086–1093

  7. Hoyen CK, Pultz NJ, Paterson DL et al (2003)
    Effect of parenteral antibiotic administration
    on establishment of intestinal colonization in
    mice by Klebsiella pneumoniae strains produc-
    ing extended-spectrum β-lactamases.
    Antimicrob Agents Chemother 47:3610–3612

  8. Pultz MJ, Donskey CJ (2007) Effects of imipe-
    nem-cilastatin, ertapenem, piperacillin-
    tazobactam, and ceftriaxone treatments on
    persistence of intestinal colonization by
    extended-spectrum-beta-lactamase-producing
    Klebsiella pneumoniae strains in mice.
    Antimicrob Agents Chemother 51:3044–3045

  9. Donskey CJ, Helfand MS, Pultz NJ et al
    (2004) Effect of parenteral fluoroquinolone
    administration on persistence of vancomycin-
    resistant Enterococcus faecium in the mouse
    gastrointestinal tract. Antimicrob Agents
    Chemother 48:326–328

  10. Boetius Hertz F, Lobner-Olesen A, Frimodt-
    Moller N (2014) Antibiotic selection of
    Escherichia coli sequence type 131 in a mouse
    intestinal colonization model. Antimicrob
    Agents Chemother 58:6139–6144
    30. Møller AK, Leatham MP, Conway T et al
    (2003) An Escherichia coli MG1655 lipopoly-
    saccharide deep-rough core mutant grows and
    survives in mouse cecal mucus but fails to colo-
    nize the mouse large intestine. Infect Immun
    71:2142–2152
    31. Perez F, Pultz MJ, Endimiani A et al (2011)
    Effect of antibiotic treatment on establishment
    and elimination of intestinal colonization by
    KPC-producing Klebsiella pneumoniae in
    mice. Antimicrob Agents Chemother
    55:2585–2589
    32. Stiefel U, Pultz NJ, Donskey CJ (2007) Effect
    of carbapenem administration on establishment
    of intestinal colonization by vancomycin-
    resistant enterococci and Klebsiella pneu-
    moniae in mice. Antimicrob Agents Chemother
    51:372–375
    33. Dobrindt U, Hacker JH, Svanborg C (2013)
    Between pathogenicity and commensalism,
    Current topics in microbiology and immunol-
    ogy. Springer, New York
    34. Oteo J, Navarro C, Cercenado E et al (2006)
    Spread of Escherichia coli strains with high-
    level cefotaxime and ceftazidime resistance
    between the community, long-term care facili-
    ties, and hospital institutions. J Clin Microbiol
    44:2359–2366
    35. Tian SF, Chen BY, Chu YZ et al (2008)
    Prevalence of rectal carriage of extended-
    spectrum b-lactamase-producing Escherichia
    coli among elderly people in community set-
    tings in China. Can J Microbiol 54:781–785
    36. Wickramasinghe NH, Xu L, Eustace A et al
    (2012) High community faecal carriage rates
    of CTX-M ESBL-producing Escherichia coli
    in a specific population group in Birmingham,
    UK. J Antimicrob Chemother
    67:1108–1113
    37. Luvsansharav U-O, Hirai I, Nakata A et al
    (2012) Prevalence of and risk factors associated
    with faecal carriage of CTX-M β-lactamase-
    producing Enterobacteriaceae in rural Thai
    communities. J Antimicrob Chemother
    67:1769–1774
    38. Nicolas-Chanoine M-H, Gruson C, Bialek-
    Davenet S et al (2013) 10-Fold increase
    (2006–11) in the rate of healthy subjects with
    extended-spectrum β-lactamase-producing
    Escherichia coli faecal carriage in a Parisian
    check-up centre. J Antimicrob Chemother
    68:562–568
    39. Nielsen KL, Godfrey PA, Stegger M et al
    (2014) Selection of unique Escherichia coli
    clones by random amplified polymorphic DNA
    (RAPD): evaluation by whole genome sequenc-
    ing. J Microbiol Methods 103:101–103


Frederik Boëtius Hertz et al.
Free download pdf